| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |